As pharma awaits FDA rules, marketing happens

Novo Nordisk's marketing partnership with diabetic race car driver Charlie Kimball is one of the most provocative examples of how pharmaceutical companies are cleverly navigating the emerging, largely unregulated social-media space. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.